54 patients with high grade malignant nhl ( stage ii 19 , stage iii 10 , stage iv 25 patients , medium age 56 years ) were treated in an ongoing study with the vim-bleo/chop-regimen : etoposide 100 mg/m2 i.v . days 1-3 , ifosfamide 1.5 g/m2 i.v . days 1-5 with mesna for prophylaxis of cystitis , methotrexate 30 mg/m2 i.v . day 3 , bleomycin 10 mg i.v . days 8 and 15 , cyclophosphamide 750 mg/m2 day 22 , adriamycin 50 mg/m2 day 22 , vincristine 1.4 mg/m2 day 22 and prednisolone 100 mg po days 1-5 and 22-26 .
C0163868
chop-regimen
C0042679
vincristine